NodThera Charts Obesity Future with First Patients Dosed in Phase 2 RESOLVE-1 Trial of Oral NLRP3 Inflammasome Inhibitor NT-0796 Pioneering small-molecule program, NT-0796, targets chronic ...

Whether your hair is thinning or shedding, these pro-backed buys can restore strands and improve their strength and ...

Telomir-1 shows promising results in restoring vision and retinal structure in age-related macular degeneration, marking a ...

Humans have spent thousands of years experimenting with weight loss aids. While Ozempic and Wegovy may be generating ...

Data from the WAYFINDER study showed clinically meaningful reductions and discontinuations of oral corticosteroids.

As summer begins to bloom, so does the opportunity to refresh your space with warmth, personality, and effortless charm. At Liz Anne Designs, we believe your home should feel like a true reflection of ...

In this video, Jay Chhablani, MD, professor of ophthalmology at University of Pittsburgh School of Medicine, discusses 24-month findings from the SAGA trial evaluating oral gildeuretinol for ...

Pfizer halted its oral obesity drug, danuglipron, in April 2025 due to liver injury concerns, a major pipeline setback. Find ...

BioAge Labs, Inc. (NASDAQ:BIOA), a clinical-stage biotech innovator, announced today the completion of IND-enabling studies ...

FA is enriched with mullite, silica, and alumina. Having such mineralogy, FA can be envisaged as a promising candidate for combating erosion and corrosion in marine environments. With this motivation, ...

Discover 7 critical gum disease warning signs that demand immediate attention. Learn prevention tips and treatment options to ...

Viking Therapeutics faces tough obesity drug rivals, with VK2735 showing promise but an uncertain edge. Find out why VKTX ...